Fluorine-18-fluorocholine PET/CT parameters predictive for hematological toxicity to radium-223 therapy in castrate-resistant prostate cancer patients with bone metastases: a pilot study.

about

Fluorine-18-fluorocholine PET/CT parameters predictive for hematological toxicity to radium-223 therapy in castrate-resistant prostate cancer patients with bone metastases: a pilot study.

Item

http://www.wikidata.org/entity/Q55603215

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Fluorine-18-fluorocholine PET/ ...... one metastases: a pilot study.

@en

Fluorine-18-fluorocholine PET/ ...... one metastases: a pilot study.

@nl

type

Item

label

Fluorine-18-fluorocholine PET/ ...... one metastases: a pilot study.

@en

Fluorine-18-fluorocholine PET/ ...... one metastases: a pilot study.

@nl

prefLabel

Fluorine-18-fluorocholine PET/ ...... one metastases: a pilot study.

@en

Fluorine-18-fluorocholine PET/ ...... one metastases: a pilot study.

@nl

P1476

Fluorine-18-fluorocholine PET/ ...... bone metastases: a pilot study

@en

P2093

Delphine Vallot

http://www.w3.org/2001/XMLSchema#string

Erwan Gabiache

http://www.w3.org/2001/XMLSchema#string

Fayçal Ben Bouallègue

http://www.w3.org/2001/XMLSchema#string

Frederic Courbon

http://www.w3.org/2001/XMLSchema#string

Ilan Tal

http://www.w3.org/2001/XMLSchema#string

Lavinia Vija Racaru

http://www.w3.org/2001/XMLSchema#string

Lawrence Dierickx

http://www.w3.org/2001/XMLSchema#string

Mathilde Bauriaud-Mallet

http://www.w3.org/2001/XMLSchema#string

Olivier Caselles

http://www.w3.org/2001/XMLSchema#string

Pierre Pascal

http://www.w3.org/2001/XMLSchema#string

P2860

Identification and importance of brown adipose tissue in adult humans

Fiji: an open-source platform for biological-image analysis.

Radionuclide Therapies in Prostate Cancer: Integrating Radium-223 in the Treatment of Patients With Metastatic Castration-Resistant Prostate Cancer

Alpha emitter radium-223 and survival in metastatic prostate cancer

Efficacy and safety of radium-223 dichloride in patients with castration-resistant prostate cancer and symptomatic bone metastases, with or without previous docetaxel use: a prespecified subgroup analysis from the randomised, double-blind, phase 3 A

Radium-223 and concomitant therapies in patients with metastatic castration-resistant prostate cancer: an international, early access, open-label, single-arm phase 3b trial.

Hematologic Safety of Radium-223 Dichloride: Baseline Prognostic Factors Associated With Myelosuppression in the ALSYMPCA Trial.

First clinical experience with alpha-emitting radium-223 in the treatment of skeletal metastases.

High-linear energy transfer irradiation targeted to skeletal metastases by the alpha-emitter 223Ra: adjuvant or alternative to conventional modalities?

P304

672-679

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/MNM.0000000000000850

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Salim Kanoun

Slimane Zerdoud

Mathieu Sinigaglia

P577

2018-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29790867

http://www.w3.org/2001/XMLSchema#string

P932

6023601

http://www.w3.org/2001/XMLSchema#string